April 8 latest advice on COVID-19 Vaccination
This latest advice regarding COVID-19 vaccination is based on a new recommendation of the Australian Technical Advisory Group on Immunisation (ATAGI), following new information on evidence of a rare but serious side effect of thrombosis in younger people.
The advice states:
- ATAGI recommends that the COVID-19 vaccine by Pfizer is preferred over COVID-19 Vaccine AstraZeneca in adults aged under 50 years.
- COVID-19 Vaccine AstraZeneca can be used in adults aged under 50 years – where the benefits are likely to outweigh the risks for that individual and the person has made an informed decision based on an understanding of the risks and benefits.
- People who have had the first dose of COVID-19 Vaccine AstraZeneca without any serious adverse effects can be given the second dose, including adults under 50 years.